Importance of antibiotic dosing in critically Ill patients

Current Pharmaceutical Biotechnology

Volumn 12, Issue 12, 2011, Pages 1981-1982

  Roberts, Jason A ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CRITICALLY ILL PATIENT; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG PENETRATION; EDITORIAL; HUMAN; INFECTION CONTROL; KIDNEY CLEARANCE; MAINTENANCE THERAPY; PHARMACODYNAMICS; RENAL REPLACEMENT THERAPY; CRITICAL ILLNESS;

ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; HUMANS;

EID: 82955182471     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111798808310     Document Type: Editorial

References (11)

1. Patel, K.; Kirkpatrick, C.M.J. Pharmacokinetic concepts revisited-basic and applied. Curr. Pharm. Biotechnol. 2011, 1983-1990.
2. Hosein, S.; Udy, A.A. Lipman, J. Physiological Changes in the Critically Ill Patient with Sepsis. Curr. Pharm. Biotechnol., 2011, 1991-1995.
3. Ulldemolins, M.; Rello J. The relevance of drug volume of distribution in antibiotic dosing Curr. Pharm. Biotechnol., 2011, 1996-2001.
4. Roberts, D.M. The relevance of drug clearance to antibiotic dosing in critically ill patients. Curr. Pharm. Biotechnol., 2011, 2002- 2014.
5. Kielstein, J.; Burkhardt, O. Dosing of antibiotics in critically ill patients undergoing renal replacement therapy Curr. Pharm. Biotechnol., 2011, 2015-2019.
6. Udy, A.A.; Putt, M.; Boots, R.J.; Lipman, J. ARC - augmented renal clearance. Curr. Pharm. Biotechnol., 2011, 2020-2029.
7. Gonzalez, D.; Conrado, D.J.; Theuretzbacher U.; Derendorf H. The effect of critical illness on drug distribution. Curr. Pharm. Biotechnol., 2011, 2030-2036.
8. Liu, X.; Kruger, P.S.; Roberts M.S. How to measure pharmacokinetics in critically ill patients? Curr. Pharm. Biotechnol., 2011, 2037-2043.
9. Bulitta, J.B.; Landersdorfer, C.B.; Forrest, A.; Brown, S.V.; Tsuji, B.T.; Louie, A. Relevance of pharmacokinetic and pharmacodynamic modelling to clinical care of critically ill patients Curr. Pharm. Biotechnol., 2011, 2044 2061.
10. Deege, M.P.D.; Paterson, D.L. Reducing the development of antibiotic resistance in critical care units. Curr. Pharm. Biotechnol., 2011, 2062-2069.
11. Roberts, J.A. Using PK/PD to optimize antibiotic dosing for critically ill patients. Curr. Pharm. Biotechnol., 2011, 2070-2079.